Salarius Pharmaceuticals, Inc (SLRX)

Etorro trading 970x250
Salarius Pharmaceuticals, Inc (SLRX) Logo

About Salarius Pharmaceuticals, Inc

Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. The company’s lead candidate is Seclidemstat (SP-2577), which is in Phase I/II clinical trial for the treatment of advanced solid tumors, including prostate, breast, and ovarian cancers, as well as Ewing sarcoma. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds; HLB Life Sciences to develop, produce, manufacture, use, and sell the drug in South Korea; and Cancer Prevention and Research Institute of Texas for product development activities. Salarius Pharmaceuticals, Inc. is headquartered in Houston, Texas. Address: 2450 Holcombe Boulevard, Houston, TX, United States, 77021

Salarius Pharmaceuticals, Inc News and around…

Latest news about Salarius Pharmaceuticals, Inc (SLRX) common stock and company :

Salarius Pharmaceuticals to Participate in Annual Benchmark Company Discovery One-on-One Conference
29 Nov, 2021 Yahoo! Finance

HOUSTON, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with sarcomas, pediatric cancers, and other hematologic and solid cancers, announced today that its chief executive officer, David Arthur, and other members of the Company’s management team will participate in the Benchmark Company Discovery One-on-One Investor Conference. The conference is taking place via an all-vir

12 Health Care Stocks Moving In Thursday's After-Market Session
18 Nov, 2021 FinancialContent

Gainers NeuroOne Medical Tech (NASDAQ:NMTC) stock moved upwards by 6.47% to $2.63 during Thursday's after-market session. The ...

Salarius Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress
04 Nov, 2021 Yahoo! Finance

Cash and Cash Equivalents of $31.9 Million Sufficient to Fund Completion of Ongoing Clinical Trials for Lead Drug Candidate Seclidemstat Added Five New Clinical Sites to Sarcoma Trial; 13 Active Sites Now Supporting Enrollment Initial Ewing Sarcoma Combination Therapy Safety Lead-in Cohort Fully Enrolled, FET-Rearranged Sarcoma Patient Enrollment Continuing Conference Call and Live Audio Webcast Scheduled for Today, November 4, 2021, 5:00 p.m. ET HOUSTON, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Salari

Will Salarius (SLRX) Report Negative Earnings Next Week? What You Should Know
28 Oct, 2021 Yahoo! Finance

Salarius (SLRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Salarius Pharmaceuticals to Report Third Quarter 2021 Financial Results and Highlight Recent Company Progress
26 Oct, 2021 Yahoo! Finance

Conference Call and Live Audio Webcast Scheduled for Thursday, November 4, 2021, 5:00 p.m. ETHOUSTON, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with sarcomas, pediatric cancers, and other hematologic and solid tumors, today announced that the Company will host a conference call and live audio webcast on Thursday, November 4, 2021, at 5:00 p.m. ET, to discuss its corpo

Could the Future Hold a Less Toxic Cancer Treatment in the Form of a Tablet?
18 Oct, 2021 FinancialContent

Image by PublicDomainPictures from Pixabay The following post was written and/or published as a collaboration between ...

Salarius Pharmaceuticals and Nationwide Children’s Hospital Disclose Research Findings from Presentation at 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
07 Oct, 2021 Yahoo! Finance

HOUSTON, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, and Nationwide Children’s Hospital announced today research findings from their presentation at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics. The conference begins today, October 7, 2021, and runs through

Salarius Pharmaceuticals to Present at the 2021 BioFuture Conference
05 Oct, 2021 Yahoo! Finance

HOUSTON, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with sarcomas, pediatric cancers, and other hematologic and solid tumors, announced today that David Arthur, Chief Executive Officer, will present virtually at the 2021 BioFuture Conference. The event will be held in New York City on October 5-6, 2021, at Cure, Deerfield Management Company’s vertical healthcare-dedica

Salarius Pharmaceuticals and Nationwide Children’s Hospital Announce Poster Presentation at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
30 Sep, 2021 FinancialContent
Biocept: A New Diagnostic Approach to Improve the Lives of Cancer Patients
29 Sep, 2021 FinancialContent

Battling cancer is often a long journey—and one that becomes even more challenging for the large number of patients who find that ...

Salarius Pharmaceuticals Receives $2.7 Million in Payment from the Cancer Prevention and Research Institute of Texas
28 Sep, 2021 FinancialContent
Salarius Pharmaceuticals to Present at the Virtual Benzinga Healthcare Small Cap Conference
27 Sep, 2021 FinancialContent
Salarius Pharmaceuticals and Fox Chase Cancer Center Launch Research Partnership
22 Sep, 2021 FinancialContent
35 Stocks Moving In Monday's Mid-Day Session
20 Sep, 2021 FinancialContent

Gainers ZIVO Bioscience, Inc. (NASDAQ: ZIVO) jumped 145% to $6.86 after declining around 17% on Friday. Edesa Biotech, Inc. ...

Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
20 Sep, 2021 FinancialContent

Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentations

Salarius Pharmaceuticals Added to FTSE Global Micro Cap Index
20 Sep, 2021 FinancialContent
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
20 Sep, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, trader! We're starting off the week right with a dive into the biggest pre-market stock movers for Monday morning. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

24 Stocks Moving in Monday's Pre-Market Session
20 Sep, 2021 FinancialContent

Gainers Verastem, Inc. (NASDAQ: VSTM) rose 30.8% to $3.61 in pre-market trading after the company announced a mini oral ...

12 Health Care Stocks Moving In Friday's After-Market Session
17 Sep, 2021 FinancialContent

Gainers Corvus Pharmaceuticals (NASDAQ:CRVS) shares moved upwards by 8.27% to $5.76 during Friday's after-market session. This ...

Salarius Pharmaceuticals to Present at the Virtual Life Science Investor Forum
15 Sep, 2021 FinancialContent
Life Sciences Virtual Investor Conference: Company Executives Present Live September 16th
10 Sep, 2021 FinancialContent

Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com

Salarius Pharmaceuticals to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference
08 Sep, 2021 FinancialContent
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
08 Sep, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, trader! We're kicking off the day with an overview of the biggest pre-market stock movers for Wednesday to keep an eye on! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

4 Robinhood Penny Stocks to Watch Under $2 Right Now
07 Sep, 2021 FinancialContent
Salarius Pharmaceuticals's Return On Capital Employed Overview
07 Sep, 2021 FinancialContent

Benzinga Pro data, Salarius Pharmaceuticals (NASDAQ:SLRX) reported Q2 sales of $571.39 thousand. Earnings fell to a loss of $3.12 ...

20 Stocks Moving in Friday's Pre-Market Session
03 Sep, 2021 FinancialContent

Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 59.5% to $8.77 in pre-market trading after the company announced the ...

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2021
25 Aug, 2021 FinancialContent

Upgrades For Kite Realty Group Trust (NYSE:KRG), Raymond James upgraded the previous rating of Outperform to Strong Buy. ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
25 Aug, 2021 FinancialContent

Gainers Regencell Bioscience (NASDAQ:RGC) stock increased by 25.49% to $19.2 during Wednesday's pre-market session. ...

12 Health Care Stocks Moving In Tuesday's After-Market Session
24 Aug, 2021 FinancialContent

Gainers Regencell Bioscience (NASDAQ:RGC) stock rose 51.24% to $23.14 during Tuesday's after-market session. Regencell Bioscience's ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
24 Aug, 2021 FinancialContent

Gainers Triple-S Management (NYSE:GTS) stock moved upwards by 44.27% to $34.9 during Tuesday's pre-market session. ...

Salarius Pharmaceuticals, Inc (SLRX) is a NASDAQ Common Stock listed in , ,

970x250